Buy side Archive

As China celebrates its New Year, many investors will be hoping the Year of the Pig doesn’t live up to its name – and the expectation is that it won’t. Like most of the world’s capital markets, Chinese stocks ended 2018 on a sour note, with both the Shanghai and Shenzhen stock indices slumping into bear market territory for the year at -25 percent and -35 percent, respectively. ‘Just as there were several contributing factors to the remarkable retur...

Exchange-traded fund (ETF) providers are turning to more expensive strategic beta and actively managed strategies after rapid industry growth froze last year with the end-of-year stock market turmoil. More than half (57 percent) of ETF issuers highlight that they are developing strategic beta strategies – which use rules-based strategies that are not necessarily market-weighted – compared with 41 percent of issuers that report developing active ETFs and 36 perce...

The UK biotech sector was given a massive boost last year when it raised a record £2.2 bn ($2.9 bn) from investors. New figures in a report from the UK BioIndustry Association (BIA) and Informa Pharma Intelligence – ‘Confident capital: backing UK biotech’ – show the total is the best ever recorded, and almost double the £1.2 bn raised by UK-based biotech co...

Investors’ expectations for global GDP growth continue to fall, as 60 percent of those surveyed in the Bank of America Merrill Lynch (BofAML) January Fund Manager Survey think global growth will weaken over the next 12 months. This is the worst outlook on the global economy since July 2008 and below the trough seen in January 2001. This month’s survey finds the worst outlook on profits since 2008, with 52 percent of investors expecting global profits to d...